Member Info for Aether

XD

Now we know who Spaceman is.

Gunto2022 They're linked on ADVFN.

A green rectangle.

The number of patients in each P2 mini-trial will be small.

The genetic tests are going to be very important.

How much will the sp increase if there is a successful P2?

Hopefully, the new genetic tests (from Casanova Labs, etc.) will target the right patients.

If the P2 trials are successful, I will sell up. I do not trust the management to run a P3.

I am over-extended in this share.

GLALTI

Yes, I recall someone stating that BP and Gov wouldn't be interested in SNG until there is further data. It was recorded during a conversation with a director after the main AGM presentation this year. The phrase "opening the flood gates" was used.

So, we have to wait for P2 results.

Given the situation, I am prepared to wait until there are effective tests (e.g. from UNIVERSAL and Cazanova) to determine suitable patients to ensure a greater chance of success.

The upcoming P2 mini-trials won't just be for COVID?

"... and, we hope and trust, more rigorous selection criteria and monitoring BY SNG (!) than was the case certainly for the ACTIV study."

100%

I hope SNG are competent and aware of this and will act on it.

Good question.

They need 1000 patients for the study but at the time of writing-up this part of the study they only had 100?

This is an important study for us.

Will they have enough patients/data to inform the design of P2 mini-trials by December?

A green rectangle.

Thanks Bryosa.

That UNIVERSAL presentation was supposed to be important because it would allow BP to gauge the size of the market.

Has anyone seen this poster?

Thank you.

I thought this was an update on UNIVERSAL.

What is this presentation about?

From the grainy photos, it doesn't seem to say much about UNIVERSAL.

Green rectangle.

Has anyone who actually owns SNG shares seen the presentation?

Has anyone who actually owns SNG shares seen the presentation?

Isn't UNIVERSAL supposed to be delivering something today?

Someone responded to a clickbaiter and this is what happens.

XD

Ignore it.

IIRC the importance of the study includes:

1. Identifying which patients will benefit the most from SNG (vital for planning the P2 trials), *and*

2. Determining whether the market was large enough for BP to invest.

So, the outcome is important for Synairgen.

Why has it's share price collapsed?

90% over six months.

30% over the last five days.

Holding SNG feels like living through a Russian novel!